Web Collection: Emerging therapeutic targets for T2DM

If you are unable to see the message below, click here to view.

Web Collection: Emerging therapeutic targets for T2DM Impact factor 11.025* Type 2 diabetes mellitus (T2DM) is one of the most prevalent noncommunicable diseases in the world. Traditional pharmacological agents for the management of glycaemic control in patients with T2DM include metformin, sulphonylureas and insulin. However, research in the past decade has uncovered new therapeutic targets for T2DM, some of which have reached clinical application. This Nature Reviews Endocrinology collection provides an overview of the emerging therapeutic targets for T2DM, discussing promising therapeutic avenues for T2DM uncovered from basic, translational and clinical research. FREE online for 6 months thanks to support from Boehringer Ingelheim *2012 Journal Citation Report®(Thomson Reuters, 2013). FOLLOW US: RSS   Twitter   Monthly e-alert As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries. Nature Publishing Group | Principal offices: London | New York and Tokyo, and offices in cities worldwide including Boston | Buenos Aires | Cairo | Delhi | Mumbai | Hong Kong | Madrid | Barcelona | Munich | Heidelberg | Basingstoke | Melbourne | Paris | San Francisco | Seoul and Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | 75 Varick St Fl 9 | New York | NY 10013-1917 | USA © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.